Org.nr 985 889 635 2008 → 2009 Year-over-year analysis

LYTIX BIOPHARMA ASA: årsregnskap 2009 vs 2008

Stronger earnings

Summary

What changed

Comparing Årsregnskap 2009 with 2008 for LYTIX BIOPHARMA ASA. Net result -34.29m NOK → -26.37m NOK. Equity 83.48m NOK → 72.04m NOK.

On the constructive side: operating result improved; net result improved; cash rose. Pressures included: equity eroded.

Also worth watching: paid-in equity reduced. All figures are taken from the published annual accounts for LYTIX BIOPHARMA ASA.

At a glance

Revenue

300 NOK n/m

—

Operating result

-36.75m NOK -28.06m NOK

+23.6%

Net result

-34.29m NOK -26.37m NOK

+23.1%

Equity

83.48m NOK 72.04m NOK

-13.7%

Cash

16.44m NOK 70.90m NOK

+331.4%

Total assets

94.00m NOK 84.90m NOK

-9.7%

↑
Operating result improved

Operating result -36.75m NOK → -28.06m NOK. Calculated
↑
Net result improved

Net result -34.29m NOK → -26.37m NOK. Calculated
↑
Cash rose

Bank deposits 16.44m NOK → 70.90m NOK (+331.4% YoY). Calculated

↓
Equity eroded

Book equity 83.48m NOK → 72.04m NOK (equity ratio 88.8% → 84.9%). Calculated

·
Paid-in equity reduced

Paid-in equity fell 83.48m NOK → 72.04m NOK — check capital reduction, conversion, or reclassification. Interpretation